ライフサイエンスコーパス: osteoblast differentiation

1 a critical transcription factor required for osteoblast differentiation.

2 suppression of which is sufficient to induce osteoblast differentiation.

3 cer cell viability, osteoclast formation and osteoblast differentiation.

4 n Wnt signaling and subsequent inhibition of osteoblast differentiation.

5 ppaB ligand (RANKL)-binding peptide promotes osteoblast differentiation.

6 f Osx level to fine-tune its activity during osteoblast differentiation.

7 Fbw7alpha restored Runx2 levels and promoted osteoblast differentiation.

8 otubules by pretreatment with Taxol inhibits osteoblast differentiation.

9 ates the mTORC2-Akt signaling cascade during osteoblast differentiation.

10 lso led to reduced Runx2 transactivation and osteoblast differentiation.

11 wed that Hdac7 suppresses Runx2 activity and osteoblast differentiation.

12 cerbated osteoclast activation and defective osteoblast differentiation.

13 ession of Runx2, the earliest determinant of osteoblast differentiation.

14 involved in wound healing, angiogenesis, and osteoblast differentiation.

15 identify pathways responsible for decreased osteoblast differentiation.

16 -bp sequence that mediates responsiveness to osteoblast differentiation.

17 d to uncover osteogenic miRs of interest for osteoblast differentiation.

18 ed proliferation and concurrent induction of osteoblast differentiation.

19 organization of the Runx2-P1 promoter during osteoblast differentiation.

20 nd Schnurri-2, which have been implicated in osteoblast differentiation.

21 /beta-catenin interactions are necessary for osteoblast differentiation.

22 osphatase and osterix that are necessary for osteoblast differentiation.

23 rs in a large number of processes, including osteoblast differentiation.

24 PI 3-kinase)/Akt signaling by BMP-2 leads to osteoblast differentiation.

25 MP-2-down-regulated miRNA, as a regulator of osteoblast differentiation.

26 contributor to the cell-cell contact-induced osteoblast differentiation.

27 ependent osteocalcin (Ocn) transcription and osteoblast differentiation.

28 h expression and for its paracrine effect on osteoblast differentiation.

29 ix protein that is a critical determinant of osteoblast differentiation.

30 -34) is significantly induced by BMP2 during osteoblast differentiation.

31 , B3 receptors on the osteoblast to suppress osteoblast differentiation.

32 ic pathway by which these microRNAs regulate osteoblast differentiation.

33 ion of Sost, Wnt-beta-catenin signaling, and osteoblast differentiation.

34 PS patients, was associated with an abnormal osteoblast differentiation.

35 ption factor required for bone formation and osteoblast differentiation.

36 sion of ATF4-dependent Ocn transcription and osteoblast differentiation.

37 ion as well as Wnt-induced proliferation and osteoblast differentiation.

38 of Runx2, a transcription factor integral to osteoblast differentiation.

39 hannel and gap junction activities inhibited osteoblast differentiation.

40 luding the MEKK2 signaling pathway, inducing osteoblast differentiation.

41 of Dkk2 mRNA, which plays a role in terminal osteoblast differentiation.

42 Tcf reporter activity, and promotes terminal osteoblast differentiation.

43 n Fgf2(-/-) bone marrow stromal cells during osteoblast differentiation.

44 bone destruction in mice, but also inhibits osteoblast differentiation.

45 s, plays an essential role in the control of osteoblast differentiation.

46 vation of stress-induced p38 MAPK leading to osteoblast differentiation.

47 ed in a regulatory circuit that can modulate osteoblast differentiation.

48 that Dchs1-Fat4 signalling is essential for osteoblast differentiation.

49 of the serine 68 residue (Ser68) to promote osteoblast differentiation.

50 distinct requirements for Yap and Taz during osteoblast differentiation.

51 no acids) to fuel bone formation and promote osteoblast differentiation.

52 s been extensively studied in the context of osteoblast differentiation.

53 activates alpha4beta1 integrin and augments osteoblast differentiation.

54 nt manner, without affecting TNF activity or osteoblast differentiation.

55 differentiation may occur at the expense of osteoblast differentiation.

56 Our data suggest that ANO5 plays a role in osteoblast differentiation.

57 and KDM8 are the candidate KDMs required for osteoblast differentiation.

58 roles in skeletal development by regulating osteoblast differentiation.

59 pression and show that BRD4 is essential for osteoblast differentiation.

60 ctin isoforms and the mediating receptors in osteoblast differentiation.

61 lls to and in the bone matrix, and inhibited osteoblast differentiation.

62 ce revealed that BDNF knockdown can suppress osteoblast differentiation.

63 on of a large number of genes while inducing osteoblast differentiation.

64 cells at different stages of odontoblast and osteoblast differentiation.

65 lding and cross-linking; mineralisation; and osteoblast differentiation.

66 smic acetyl-CoA levels impairs Wnt3a-induced osteoblast differentiation.

67 eloma, and TSP1-TGF-beta activation inhibits osteoblast differentiation.

68 d Gsalpha and Gq/11 act downstream of PTH on osteoblast differentiation.

69 tenin must be precisely regulated for normal osteoblast differentiation.

70 ls to secrete an inhibitor of PTH-stimulated osteoblast differentiation.

71 production, which, in addition to enhancing osteoblast differentiation, also stimulates osteoprotege

72 factors crucial for skeletal development and osteoblast differentiation among those significantly upr

73 ological inhibition of PI3K activity reduced osteoblast differentiation and abolished Wnt regulatory

74 Lithium chloride also increased osteoblast differentiation and activity in vitro in agre

75 tein TG-interacting factor 1 (Tgif1) impairs osteoblast differentiation and activity, leading to a re

76 s and bone mineral density through increased osteoblast differentiation and activity.

77 Inhibition of USP7 regulates osteoblast differentiation and adipocyte differentiation

78 sion corresponds with distinct events during osteoblast differentiation and affects bone development

79 ts demonstrated that PKD1 contributes to the osteoblast differentiation and bone development via elev

80 , we investigated whether miRs implicated in osteoblast differentiation and bone formation are involv

81 IL-3 also enhances osteoblast differentiation and bone formation from mesen

82 Alg2 suppressed osteoblast differentiation and bone formation in culture

83 ngly demonstrated that JMJD3 is required for osteoblast differentiation and bone formation in mice.

84 erentiation in vitro, its role as a whole in osteoblast differentiation and bone formation in vivo re

85 ctivity and cooperated with RUNX2 to promote osteoblast differentiation and bone formation in vivo.

86 ur findings suggest that FGF2 stimulation of osteoblast differentiation and bone formation is mediate

87 e show that p38 activity in myeloma inhibits osteoblast differentiation and bone formation, but also

88 been identified as an essential regulator of osteoblast differentiation and bone formation.

89 ors Runx2 and Osx (Osterix) are required for osteoblast differentiation and bone formation.

90 -specific transcription factor essential for osteoblast differentiation and bone formation.

91 growth factor 2 (FGF2) positively modulates osteoblast differentiation and bone formation.

92 of Gsalpha in osteoblasts, PTH can stimulate osteoblast differentiation and bone formation.

93 nt regulatory roles for type XII collagen in osteoblast differentiation and bone matrix formation.

94 Si has been demonstrated to stimulate osteoblast differentiation and bone mineralisation in vi

95 Osx) is a transcription factor essential for osteoblast differentiation and bone mineralization.

96 eletion of Jmjd3 resulted in severe delay of osteoblast differentiation and bone ossification in mice

97 uction in bone cells plays a pivotal role in osteoblast differentiation and bone remodelling.

98 g are compromised in their ability to induce osteoblast differentiation and consequently are ineffici

99 we determined that this loop is required for osteoblast differentiation and embryonic skeletal format

100 acetylase inhibitors (HDIs) promote terminal osteoblast differentiation and extracellular matrix prod

101 directs cells within the bone marrow toward osteoblast differentiation and favors the maintenance of

102 how that the DeltaF508-CFTR mutation impairs osteoblast differentiation and function as a result of o

103 pha,25-dihydroxyvitamin D3 (1,25 (OH)2D3) on osteoblast differentiation and function differ significa

104 ued Wnt target gene expression and corrected osteoblast differentiation and function in bone marrow s

105 ta-catenin signaling can rescue the abnormal osteoblast differentiation and function induced by the p

106 -like receptor 2 (TLR2) and to inhibit mouse osteoblast differentiation and function through engageme

107 Osteoblast differentiation and function were not affecte

108 5 proteins at levels appropriate for optimal osteoblast differentiation and function, at least in par

109 The latter is part of a broad defect in osteoblast differentiation and function, which also resu

110 that the DeltaF508-CFTR mutation alters both osteoblast differentiation and function.

111 /beta-catenin pathway, which is critical for osteoblast differentiation and function.

112 impacting cJUN transcriptional activity and osteoblast differentiation and function.

113 their overexpression in osteoblasts enhanced osteoblast differentiation and function.

114 d tissues and that the influence of ENPP1 on osteoblast differentiation and gene expression may inclu

115 Here, we show that miR-218 is induced during osteoblast differentiation and has potent osteogenic pro

116 aematopoietic cells stimulate proliferation, osteoblast differentiation and inhibit senescence of MSC

117 but EZH2 expression declines during terminal osteoblast differentiation and matrix production.

118 Thus, NHERF1 is required for normal osteoblast differentiation and matrix synthesis.

119 Similarly, osteoblast differentiation and mineralization were delay

120 Conversely, osteoblast differentiation and mineralization were inhib

121 Osteoblast differentiation and mineralization were stimu

122 The metabolic requirements of osteoblast differentiation and mineralization, both esse

123 Therefore, an agomir of miR-874-3p induced osteoblast differentiation and mineralization.

124 opment of the bone lineage itself, including osteoblast differentiation and morphogenetic outgrowth,

125 tional regulators that control self-renewal, osteoblast differentiation and negative Bmp autoregulati

126 uired for mesoderm- and neural crest-derived osteoblast differentiation and normal skeletal developme

127 In bone, it is known to regulate osteoblast differentiation and osteoclast activity.

128 hondrocytes co-express genes associated with osteoblast differentiation and produce extensive mineral

129 Osteoblast differentiation and proliferation are regulat

130 medium from NICD3-expressing cells enhanced osteoblast differentiation and proliferation in vitro, w

131 aN is only detectable in the later stages of osteoblast differentiation and promotes osteogenesis in

132 hat PEDF counters Wnt signaling to allow for osteoblast differentiation and provides a mechanistic in

133 mma alters the balance between adipocyte and osteoblast differentiation and provides checkpoint regul

134 defective canonical Wnt signaling, impaired osteoblast differentiation and reduced bone mineralizati

135 rest both in marrow and spleen and increased osteoblast differentiation and reduced ubiquitin-mediate

136 er activated genes included sets involved in osteoblast differentiation and response to oxidative str

137 for ARID2-containing complexes in promoting osteoblast differentiation and supports a view that the

138 tion, a reverse signal by ephrinB1 inhibited osteoblast differentiation and suppressed BSP gene expre

139 Blocking EZH2 activity promotes osteoblast differentiation and suppresses adipogenic dif

140 ysis, we inferred that Bicc1 was involved in osteoblast differentiation and that polycystic kidney di

141 agents enhanced parathyroid hormone-induced osteoblast differentiation and the ability to support os

142 iguanide group, has been shown to facilitate osteoblast differentiation and thus may exhibit a favora

143 steoblast progenitors reversed the increased osteoblast differentiation and, by boosting accumulation

144 tion with and inhibition of ERK activity and osteoblast differentiation, and knockin of a mutation in

145 miRNAs (except miR-218) significantly impede osteoblast differentiation, and their effects can be rev

146 fficacy to decrease proliferation, to induce osteoblast differentiation, and to reduce metastasis to

147 rs indicates that Vegfa-dependent effects on osteoblast differentiation are mediated by Vegf receptor

148 lying PKD1-mediated the bone development and osteoblast differentiation are not fully understood.

149 (NCEs) that have shown BMP-2 stimulation and osteoblast differentiation are reported.

150 Satb2 is critical for osteoblast differentiation as a special AT-rich binding

151 Parbendazole stimulates osteoblast differentiation as indicated by increased alk

152 et2 silencing prevents Sp7 expression during osteoblast differentiation as it impairs DNA demethylati

153 combinant Saa3 protein functionally inhibits osteoblast differentiation as reflected by reductions in

154 hypertrophic chondrocyte differentiation and osteoblast differentiation as well as the initiation of

155 knockdown significantly impaired AA-induced osteoblast differentiation, as detected by reduced expre

156 activation in MSCs contributes to decreased osteoblast differentiation associated with RA and sugges

157 ivator of nuclear factor kappa-B ligand, and osteoblast differentiation-associated genes.

158 a regulator of perichondrial vascularity and osteoblast differentiation at early stages of bone devel

159 y identified the A2BAR as a new regulator of osteoblast differentiation, bone formation, and fracture

160 m cells from NHERF1-null mice showed limited osteoblast differentiation but enhanced adipocyte differ

161 naturally occurring isothiocyanate, promotes osteoblast differentiation by epigenetic mechanisms.

162 appears to be a new regulator that promotes osteoblast differentiation by functioning as an ER Ca(2+

163 hancer-binding protein 3 (Hivep3) suppresses osteoblast differentiation by inducing proteasomal degra

164 n factor Runx2 controls bone development and osteoblast differentiation by regulating expression of a

165 Glucose uptake favors osteoblast differentiation by suppressing the AMPK-depen

166 ADAR1 regulates osteoblast differentiation by, at least in part, modulat

167 The osteoblast differentiation capacity of skeletal stem cel

168 ing factors, RANKL and PTHrP, even after the osteoblast differentiation ceases and apoptosis sets in.

169 velengths were more effective in stimulating osteoblast differentiation compared to 660 nm and 810 nm

170 Despite enhanced osteoblast differentiation, coupled osteoclastogenesis i

171 of CD47 strongly impairs SIRPalpha-dependent osteoblast differentiation, deteriorate bone formation,

172 s compared with WT MSCs, suggesting impaired osteoblast differentiation due to p85alpha deficiency in

173 ween RUNX2 and Glut1 determines the onset of osteoblast differentiation during development and the ex

174 Indian hedgehog (Ihh) is indispensable for osteoblast differentiation during embryonic development

175 edgehog (Ihh) signaling is indispensable for osteoblast differentiation during endochondral bone deve

176 al required for coordinating chondrocyte and osteoblast differentiation during endochondral bone deve

177 Spinal loading promoted osteoblast differentiation, endothelial progenitor cell

178 ce osterix (transcription factor involved in osteoblast differentiation) expression in MC3T3-E1 osteo

179 est that p85alpha plays an essential role in osteoblast differentiation from MSCs by repressing the a

180 logical stimulation of Hh signaling enhanced osteoblast differentiation from Osx-expressing cells iso

181 npo1 abrogated Oxt-induced expression of the osteoblast differentiation genes osterix (Sp7), Atf4, bo

182 fracture physiology with lower expression of osteoblast differentiation genes.

183 r beta-catenin binding and the expression of osteoblast differentiation genes.

184 Although the transcriptional regulation of osteoblast differentiation has been well characterized,

185 echanism through which Wnt signaling induces osteoblast differentiation in an osteoblast-adipocyte bi

186 o keep in mind the role of the Hh pathway in osteoblast differentiation in an otherwise predominant o

187 nc-finger transcription factor that controls osteoblast differentiation in mammals.

188 eoclastic bone resorption but did not impair osteoblast differentiation in MC3T3-E1.

189 yse the role of Dchs1-Fat4 signalling during osteoblast differentiation in mouse.

190 in signaling to induce senescence and reduce osteoblast differentiation in MSCs.

191 t and mechanisms linking maternal obesity to osteoblast differentiation in offspring.

192 Finally, MLL4 is required for efficient osteoblast differentiation in part by countering LSD1 H3

193 Thus, Wnt signaling induces osteoblast differentiation in part through histone deace

194 showed decreased proliferation and impaired osteoblast differentiation in response to BMP2 or BMP6 s

195 n tumor cells and osteoblasts and influences osteoblast differentiation in response to tumor cells.

196 that increased glycolysis is associated with osteoblast differentiation in response to Wnt signaling,

197 s study, we found defects in chondrocyte and osteoblast differentiation in Spop-null mutant mice.

198 Only Hivep3 siRNA promoted osteoblast differentiation in ST-2 cells, whereas all th

199 Hedgehog (Hh) signaling is essential for osteoblast differentiation in the endochondral skeleton

200 f either Lrp5 or Lrp6 did not overtly affect osteoblast differentiation in the mouse embryo.

201 erlapping domains of PDGF-PI3K signaling and osteoblast differentiation in the palate and increased o

202 nitors or chondrocytes resulted in premature osteoblast differentiation in the perichondrium, coupled

203 We conclude that TSH enhances osteoblast differentiation in U2OS cells that is, in par

204 related suppression of Ocn transcription and osteoblast differentiation in vitro and in vivo.

205 K4 and H3K36 (H3K36me), negatively regulates osteoblast differentiation in vitro by inhibiting the ac

206 Compound 11 induced osteoblast differentiation in vitro, and this effect was

207 , even though Hh signaling directly promotes osteoblast differentiation in vitro, constitutive activa

208 idence indicated the involvement of JMJD3 in osteoblast differentiation in vitro, its role as a whole

209 beta-catenin did induce a slight increase of osteoblast differentiation in vitro, these cells display

210 nmb, as an osteogenic factor that stimulates osteoblast differentiation in vitro.

211 erious effects on bone volume in vivo and on osteoblast differentiation in vitro.

212 signaling axis, whereas it promotes terminal osteoblast differentiation in vitro.

213 eage cells, and deletion of Glut1 diminished osteoblast differentiation in vitro.

214 one formation in vivo, nor did it compromise osteoblast differentiation in vitro.

215 ited osteoclast differentiation and promoted osteoblast differentiation in vitro.

216 a Mek/MAPK inhibitor, significantly enhanced osteoblast differentiation in WT and p85alpha(-/-) MSCs.

217 grates Wnt/beta-catenin signaling to promote osteoblast differentiation independently of cell adhesio

218 one marrow cells, alendronate did not affect osteoblast differentiation, indicating the need for pre-

219 Osteoblast differentiation is an attractive model for ti

220 eration of osteoprogenitors is increased and osteoblast differentiation is delayed.

221 Furthermore, the effect of dipyridamole on osteoblast differentiation is diminished in both A2BR- a

222 The impact of VDR, RUNX2, and C/EBPbeta on osteoblast differentiation is exemplified by their actio

223 a-catenin signalling, a pathway important in osteoblast differentiation, is modulated in the early re

224 e transcription factor RunX2, which controls osteoblast differentiation, is reduced in Pkd1 mutant mi

225 Runx2, a master regulator of osteoblast differentiation, is tightly regulated at both

226 Despite evidence of a role for pRB in osteoblast differentiation, it is unknown whether it fun

227 the role of OC as an essential modulator of osteoblast differentiation, knockdown of miR-138 or addi

228 imic, and OC small interfering RNA inhibited osteoblast differentiation marker alkaline phosphatase a

229 There was increased expression of osteoblast differentiation marker genes and reduced expr

230 iation, as detected by reduced expression of osteoblast differentiation marker genes.

231 Osteoblast differentiation markers and Wnt target gene e

232 ntifying cell densities, cell proliferation, osteoblast differentiation markers, and capillaries in h

233 ere were significantly higher mRNA levels of osteoblast differentiation markers, including COL1A1, AL

234 genes that are expressed in association with osteoblast differentiation, matrix deposition, and miner

235 s defined developmental profiles and affects osteoblast differentiation, mineralization, and calvaria

236 Chromatin immunoprecipitation analysis in an osteoblast differentiation model shows that Alpl and Bgl

237 regulating the balance between adipocyte and osteoblast differentiation of bone marrow mesenchymal pr

238 was identified as osteoinductive, enhancing osteoblast differentiation of bone marrow stromal cells.

239 a nucleoside transport inhibitor, stimulate osteoblast differentiation of cells from patients with M

240 LKB1 deficiency increased proliferation and osteoblast differentiation of Ctsk+ periosteal cells, wh

241 ng on the recruitment, proliferation, and/or osteoblast differentiation of endosteal mesenchymal prog

242 velengths were more effective in stimulating osteoblast differentiation of human adipose-derived stem

243 Osteoblast differentiation of human mesenchymal stem cel

244 on of Hh signaling impairs proliferation and osteoblast differentiation of MMPs.

245 odified MSCs and EPCs dramatically increased osteoblast differentiation of MSCs and endothelial diffe

246 PEDF inhibited adipogenesis and promoted osteoblast differentiation of murine MSCs, osteoblast pr

247 al lipids demonstrated inhibitory effects on osteoblast differentiation only after the proliferation

248 ions in SMAD6, an inhibitor of BMP - induced osteoblast differentiation (p<10(-20)).

249 analysis reveal differences in adipocyte and osteoblast differentiation pathways, bone marrow neoplas

250 During osteoblast differentiation, pRB directly targets Alpl an

251 ng osteoblasts, and show that TSH stimulates osteoblast differentiation primarily through the activat

252 scription factor network for fine-tuning the osteoblast differentiation program.

253 ning how prostate metastases subvert the MSC-osteoblast differentiation program.

254 and migration, and completely blocks the MSC-osteoblast differentiation program.

255 itro, menin modulates osteoblastogenesis and osteoblast differentiation promoted and sustained by bon

256 nificant reductions in the expression of key osteoblast differentiation regulators.

257 ates from bone-forming osteoblasts; although osteoblast differentiation requires EphrinB2, osteocytes

258 hus, the mechanism through which Ihh induces osteoblast differentiation requires other effectors in a

259 entify Dchs1-Fat4 as a signalling pathway in osteoblast differentiation, reveal its crucial role with

260 thylation, represses the master regulator of osteoblast differentiation RUNX2 to promote myogenesis i

261 orylate and activate the master regulator of osteoblast differentiation, Runx2.

262 line or genetic knockout of Akt1 stimulated osteoblast differentiation secondary to increased expres

263 The stimulation of osteoblast differentiation sets the stage for osteoclast

264 r Abl by lenti-shRNA in osteoblasts enhances osteoblast differentiation, suggesting that dasatinib en

265 the FGFR2 mutations in BBDS rescues delayed osteoblast differentiation, suggesting that p53 activati

266 Upon induction of osteoblast differentiation, T63 inhibited adipogenic dif

267 olated from these mice exhibited more robust osteoblast differentiation than normal in vitro.

268 nt signaling, is indispensable for embryonic osteoblast differentiation, the roles of the key Wnt co-

269 ionally drives Wnt-related transcription and osteoblast differentiation, thereby creating a positive

270 Thus, Bmp signaling induces osteoblast differentiation through both Smad4- and mTORC

271 ntiation, suggesting that dasatinib enhances osteoblast differentiation through inhibition of both Sr

272 dentify Galphas as a key regulator of proper osteoblast differentiation through its maintenance of a

273 g osteogenic stimulation efficiently induced osteoblast differentiation through Osx stabilization.

274 unction led to impaired bone development and osteoblast differentiation through STAT3 and p38 MAPK si

275 egulation of osteoblast markers and impaired osteoblast differentiation through STAT3 and p38 MAPK si

276 ian Hedgehog (Ihh) regulates chondrocyte and osteoblast differentiation through the Glioma-associated

277 teoblastic subpopulations including distinct osteoblast differentiation trajectories.

278 2BAR KO mice resulted in lower expression of osteoblast differentiation transcription factors and the

279 in silenced cells inhibits estrogen-induced osteoblast differentiation, transcription factor up-regu

280 the known and candidate KDMs in myoblast and osteoblast differentiation using the C2C12 cell differen

281 , inhibits PTH-stimulated cAMP signaling and osteoblast differentiation via Galphai/o signaling.

282 la) was sufficient to inhibit Panx3-mediated osteoblast differentiation via reduction of Osterix and

283 ts demonstrate that low-dose PDT can promote osteoblast differentiation via the activation of activat

284 Panx3 regulates both chondrocyte and osteoblast differentiation via the activation of intrace

285 The impaired p85alpha(-/-) osteoblast differentiation was associated with increased

286 e bone surrounding the tooth was reduced and osteoblast differentiation was disrupted likely contribu

287 yses of the molecular markers indicated that osteoblast differentiation was impaired in the mutant mo

288 The Hivep3 siRNA-mediated promotion of osteoblast differentiation was negated by forced Alg2 ex

289 Osteoblast differentiation was reduced when VEGF recepto

290 lthough it is well known that DKK-1 inhibits osteoblast differentiation, we found that together with

291 Adipocyte and osteoblast differentiation were assessed in bone marrow

292 2.7-11.3), which regulates lipid levels and osteoblast differentiation, were associated with risk of

293 ontin, a known factor of bone remodeling and osteoblast differentiation, were reduced dramatically in

294 While RUNX2 cannot induce osteoblast differentiation when glucose uptake is compro

295 icagrelor and dipyridamole on osteoclast and osteoblast differentiation whereas A2BR blockade abrogat

296 us expression of each of the miRs suppressed osteoblast differentiation, whereas antagomirs increased

297 ERalpha inhibited proliferation and induced osteoblast differentiation, whereas knockout of ERalpha

298 from MDA-PCa-118b induced a higher level of osteoblast differentiation, which was significantly redu

299 sion levels confirmed a defect of Postn(-/-) osteoblast differentiation with and without PTH, as well

300 n of the Adar1 gene significantly suppressed osteoblast differentiation without affecting osteoclast